I personally think it will be a gamechanger, i have a few family members who work in hospitals and they are all in agreement that remote patient monitoring is now inevitable. Passive blood pressure monitoring in conjunction with algorithmic data analysis and interpretation is fundamental to this process so the tech is well placed to become ubiquitous, much like navigation systems in cars or camera tech in phones.
But there's been alot of negativity here around governance, as the CEO and another director are also the largest shareholders, and they have a debt for equity arrangement in place to finance the launch and commercialization of their newest product.
Do some research, would welcome your thoughts, and again, well done on NEU, you deserve everything you've earned there.
CDX Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held
